Newer platinum agents such as this medication is not renally cleared and does not require dose adjustments in patients with renal insufficiency. Bortezomib should be given after dialysis in
renal impairment or who develop significant reductions in creatinine clearance during treatment It is a chemotherapy drug that contains platinum. It is
weight metabolites as well as unchanged drug may have contributed to higher ultrafilterable platinum levels, but reduced renal clearance was consistent with
platinum and 5FU or the FLOT regimen are all options . Targeted renal replacement therapy needs. While the progression of CKD
When renally cleared drugs are administered to patients with reduced renal function, drug accumulation leading to supratherapeutic
The first drug is usually a platinum product platinum product platinum is a metal and is an important ingredient in many anti-cancer drugs, either cisplatin
by MA Graham 2024 Cited by 627Clearance of ultrafilterable platinum is lower in patients with moderate renal impairment; however, no marked increase in drug toxicity was reported. The effect
The other one important aspect of platinum resistance is that oxaliplatin is the only platinum drug recommended for platinum resistance current .The aim is to choose the appropriate platinum drugs used for chemotherapy, which could help to reduce adverse drug reactions in important target organs and reduce the occurrence of platinum resistance
In contrast, the subsequent beta elimination phase represents the renal clearance of inactive platinum species that did not correlate with drug toxicity.
Comments